Publication: 3410

Publication: 3410

Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Blood Adv vol 5 (22) 4691-4700

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: Received

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 11

Parents:: 2570 2987
Children:: None

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:: BristolMyers Squibb
Grants:: U10CA180821, U10CA180882, U24CA198171, P30-CA47904, R50-CA211241, CA04326, CA23108, UG1CA233180, UG1CA233184, UG1CA233191, UG1CA233323, UG1CA233327, UG1CA233331, UG1CA233339 , U10CA180820, UG1CA233277 (ECOG-ACRIN), U10CA180888 (SWOG)

Corr. Author:
Authors:: Matthew J. Wieduwilt Jun Yin Meir Wetzler Geoffrey L. Uy Bayard L. Powell Jonathan E. Kolitz Michaela Liedtke Wendy Stock Jan H. Beumer Ryan J. Mattison Elizabeth Storrick Susan M. Christner Lionel D. Lewis Steven Devine Richard M. Stone Richard A. Larson

Networks:: LAPS-IL057, LAPS-MA036, LAPS-MD017, LAPS-MO011, LAPS-NH012, LAPS-OH007, LAPS-WI020, NC002, NORTHWELL

Study: CALGB-10701
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: 20, 24, 31, Clinical Trials and Observations